Met Life Investment Management, LLC Eledon Pharmaceuticals, Inc. Transaction History
Met Life Investment Management, LLC
- $16.5 Billion
- Q2 2025
A detailed history of Met Life Investment Management, LLC transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 36,264 shares of ELDN stock, worth $126,561. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,264Holding current value
$126,561% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
88Shares Held
36.8MCall Options Held
48.5KPut Options Held
30.3K-
Bvf Inc San Francisco, CA6.29MShares$22 Million0.67% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.57MShares$12.4 Million0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.32MShares$11.6 Million0.0% of portfolio
-
First Light Asset Management, LLC Edina, MN2.6MShares$9.08 Million1.08% of portfolio
-
Sphera Funds Management Ltd. Tel Aviv, L31.96MShares$6.84 Million1.46% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $48M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...